Entreprise · 25/10/20071 min de lecture
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV Infection (“Lookback”)
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV Infection ("Lookback")" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.